Multaq and Urticaria - a phase IV clinical study of FDA data
Summary:
Urticaria is reported as a side effect among people who take Multaq (dronedarone hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Eliquis, and have Stroke.
The phase IV clinical study analyzes which people have Urticaria when taking Multaq. It is created by eHealthMe based on reports of 10,572 people who have side effects when taking Multaq from the FDA, and is updated regularly.
What is Multaq?
Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.
What is Urticaria?
Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,623 drugs and 2,952 conditions by eHealthMe. Check the latest studies of Urticaria.
10,572 people reported to have side effects when taking Multaq.
Among them, 56 people (0.53%) have Urticaria.

Among these 56 people:
How long have people been on Multaq when they have Urticaria? *
- < 1 month: 77.27 %
- 1 - 6 months: 13.64 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 9.09 %
- 10+ years: 0.0 %
What is the gender of people who have Urticaria when taking Multaq? *
- female: 63.64 %
- male: 36.36 %
What is the age of people who have Urticaria when taking Multaq? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 15 %
- 60+: 85 %
What are other drugs people take besides Multaq? *
- Eliquis: 7 people, 12.50%
- Lipitor: 5 people, 8.93%
- Xarelto: 5 people, 8.93%
- Lopressor: 4 people, 7.14%
- Synthroid: 4 people, 7.14%
- Aspirin: 3 people, 5.36%
- Coumadin: 3 people, 5.36%
- Vicodin: 3 people, 5.36%
- Pradaxa: 3 people, 5.36%
- Atenolol: 3 people, 5.36%
What are other side effects people have besides Urticaria? *
- Rashes (redness): 20 people, 35.71%
- Itching: 18 people, 32.14%
- Peripheral Swelling: 7 people, 12.50%
- Hypersensitivity: 6 people, 10.71%
- Head Injury: 6 people, 10.71%
- Nosebleed (bleeding from nose): 6 people, 10.71%
- Fatigue (feeling of tiredness): 6 people, 10.71%
- Wound Haemorrhage (bleeding wound): 6 people, 10.71%
- Tremor (trembling or shaking movements in one or more parts of your body): 6 people, 10.71%
- Skin Swelling: 5 people, 8.93%
What are the existing conditions these people have? *
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 8.93%
- High Blood Pressure: 4 people, 7.14%
- High Blood Cholesterol: 4 people, 7.14%
- Thyroid Diseases: 3 people, 5.36%
- Pain: 2 people, 3.57%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 3.57%
- Hair Loss: 1 person, 1.79%
- Cardiac Failure Chronic: 1 person, 1.79%
- Chest Pain: 1 person, 1.79%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 1.79%
* Approximation only. Some reports may have incomplete information.
Do you take Multaq and have Urticaria?
- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Multaq:
- Multaq (11,053 reports)
Urticaria treatments and more:
- Urticaria (173,777 reports)
How severe was Urticaria and when was it recovered:
Expand to all the drugs that have ingredients of dronedarone hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Multaq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Urticaria:
- Urticaria (2,623 drugs)
Browse all the conditions that are associated with Urticaria:
- Urticaria (2,952 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on dronedarone hydrochloride (the active ingredients of Multaq) and Multaq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Trasylol cause Renal Impairment? - 3 seconds ago
- Drug interactions of Dronabinol and Symdeko - 4 seconds ago
- Could Montelukast Sodium cause Injection Site Urticaria? - 10 seconds ago
- Drug interactions of Tecfidera and Nystatin - 15 seconds ago
- Could Synjardy Xr cause Drug Ineffective? - 16 seconds ago
- Drug interactions of Cyanocobalamin and Clopidogrel - 17 seconds ago
- Drug interactions of Sensipar and Protonix - 19 seconds ago
- Could Symbyax cause Oropharyngeal Pain? - 36 seconds ago
- Could Aleve cause General Symptom? - 38 seconds ago
- Could Sutent cause Back Pain? - 48 seconds ago